Stock Ticker

  • Loading stock data...

Valeant Pharmaceuticals Intl Inc (NYSE:VRX) May Soon Announce Its Name Change, Sources Reveal

Valeant Pharmaceuticals Intl Inc (NYSE:VRX) in a number of its board meetings has had the matter about a name change delved into in a great way. This is still on the weighing balance and eyes are wide open to see what actually happens. The company’s chief executive Joseph Papa while making a statement outlined that […]

Eyegate Pharmaceuticals Inc (NASDAQ:EYEG) Licensing Deal Assessment And Breakdown

A major independent equity research firm focused on micro-cap and small-cap stocks, Traders News Source released a comprehensive assessment of Eyegate Pharmaceuticals Inc (NASDAQ:EYEG) licensing deal with major biotech Valeant Pharmaceuticals Intl Inc (NYSE:VRX) in full report. The company reported an exclusive licensing deal with Valeant on February 21, 2017. As per the terms of […]

Allergan, Inc. (NYSE:AGN) Issues A Statement regarding Correspondence With Valeant Pharmaceuticals Intl Inc(NYSE:VRX)

Boston, MA 09/26/2014 (wallstreetpr) – According to reports, Allergan, Inc. (NYSE:AGN) has issued a statement consisting important information about its recent correspondence with Valeant Pharmaceuticals Intl Inc (NYSE:VRX). The statement was published by VRX sometime back. Management Call: Board of Directors of Allergan, Inc. (NYSE:AGN) is completely aware from the ongoing situation with VRX and its […]

Valeant Pharmaceuticals Intl Inc (NYSE:VRX) Strengthens Itself In Battle To Acquire Allergan, Inc. (NYSE:AGN)

Boston, MA 09/25/2014 (wallstreetpr) – Valeant Pharmaceuticals Intl Inc (NYSE:VRX) yesterday said that its revenue for Q3, 2014 will be stronger than anticipated. The company pushed Allegan harder to accept its offer on this pretext. Better-Than-Expected Results Formerly known as Biovail Corporation, Valeant, said it expects the following quarter’s revenue figures to be higher than those […]

Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) Acquisition Likely To Aid Allergan, Inc. (NYSE:AGN) Avert Ackman’s Proposal

Boston, MA 09/24/2014 (wallstreetpr) – The talks about a merger between Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) and Botox-maker, Allergan, Inc. (NYSE:AGN) have infuriated activist investor William Ackman, who has threatened to sue the later, if the deal finalizes. Take-Over Battle Mr. Ackman is supporting and pushing the idea of Valeant Pharmaceuticals Intl Inc (NYSE:VRX) acquiring Allergan. However, […]

Support Grows For Special Meeting Of Allergan, Inc. (NYSE:AGN) Shareholders

Boston, MA 09/12/2014 (wallstreetpr) – More investors in Allergan, Inc. (NYSE:AGN) continue to show their support for a special shareholder meeting, The Wall Street Journal stated in an article. The meeting is being sought by William Ackman’s Pershing Square Capital Management LP and Valeant Pharmaceuticals Intl Inc (NYSE:VRX). The two are seeking to take over […]

Allergan, Inc. (NYSE:AGN) And Valeant Pharmaceuticals Intl Inc (NYSE:VRX) Fight Taking A Legal Shape As Latter Files A Lawsuit

Boston, MA 08/25/2014 (wallstreetpr) – In order to put the acquisition of Allergan, Inc. (NYSE:AGN) deal in the fastest gear, Valeant Pharmaceuticals Intl Inc (NYSE:VRX) as well as William Ackman (Pershing Square Capital Management LP activist), are taking the lawsuit path. In the hostile $53 billion acquisition bid for Allergan, the two are looking forward to […]

Are Investors of Allergan, Inc. (NYSE:AGN) Taken For a Ride By Hedge Fund? Are Hedge Funds In Collusion Course On Allergan, Inc. (NYSE:AGN) Shares?

Boston, MA 08/15/2014 (wallstreetpr) – Are head fund companies made a big money out of Allergan, Inc. (NYSE:AGN)’s potential bid to be sold or a takeover target company? If so, are the investors taken for a ride? If reports are to be believed, the regulator, Securities Exchange Commission or the SEC, seemed to have seized […]

Valeant Pharmaceuticals Intl Inc. (NYSE:VRX) Announces Q2 Earning Results, Allergan, Inc. (NYSE: AGN) Comments

Boston, MA 08/06/2014 (wallstreetpr) – Allergan, Inc. (NYSE: AGN) commented on the Q2 earnings results announced by Valeant Pharmaceuticals Intl Inc. (NYSE:VRX) recently. VRX announced the results on July 31st, 2014 which were analyzed by the financial advisors and forensic accountants of AGN. What did Allergan say: According to reports published by AGN, there were […]

Allergan, Inc. (NYSE:AGN) To Meet FDA Over Rejected Drug

Boston, MA 07/01/2014 (wallstreetpr) – Allergan, Inc. (NYSE:AGN) plans to meet the Food and Drug Administration to discuss the way forward for its rejected treatment known as Levadex or Semprana. The drug is being offered as a migraine inhaler. However, the regulator refused to approve the treatment citing a problem with the delivery device of […]

Morgan Stanley (NYSE:MS) Pitched Its Defense Services To Allergan

Boston, MA 06/19/2014 (wallstreetpr) – Morgan Stanley (NYSE:MS) is the advice-giver to the Canada based pharmaceutical company, Valeant Pharmaceuticals Intl Inc (NYSE:VRX) in its $53 billion bid for Allergan, Inc. (NYSE:AGN). Morgan Stanley, the global financial service firm initially attempted to get appointed by Allergan. According to Allergan, Morgan Stanley is the unwanted bidder in […]

Allergan, Inc. (NYSE:AGN) Loses Latisse Eyelash Ruling; Rejects Valeant Pharmaceuticals Intl Inc (NYSE:VRX) Offer

Boston, MA 06/11/2014 (wallstreetpr) – Allergan, Inc. (NYSE:AGN), the Botox wrinkle therapy maker, lost a ruling in the appeals court which will cause generic versions of the company’s Latisse eyelash medicine enter the marketplace. Ruling Rejected Allergan, Inc. (NYSE:AGN) and Duke University owned two patents on its drug Latisse but as per the website posting, […]

Valeant Pharmaceuticals Intl Inc (NYSE:VRX): Will its Sweetened Bid Enthuse Allergan, Inc. (NYSE:AGN) Shareholders?

Boston, MA 06/05/2014 (wallstreetpr) – Multinational, specialty pharmaceutical company Valeant Pharmaceuticals International Inc (NYSE:VRX) has recently boosted its aggressive unsolicited bid to buy another healthcare company, Allergan, Inc. (NYSE:AGN), subject to the two sides engagement in negotiations to reach an agreement. Will Allergan management and its shareholders agree to Valeant Pharmaceuticals International’s latest overtures? Sweetened Bid […]

Allergan, Inc. (NYSE:AGN) Under Pressure After William Ackman Seeks Removal Of Allergan Directors

Boston, MA 06/05/2014 (wallstreetpr) – Allergan, Inc. (NYSE:AGN) came under pressure after William Ackman, the activist investor and Valeant Pharmaceuticals Intl Inc (NYSE:VRX) paved way for $52.7 billion takeover on June 2, 2014. The Act of Informal Shareholder Referendum With this, the plans of informal shareholder referendum were also dropped. It was said that the […]

Valeant Pharmaceuticals Intl Inc (NYSE:VRX) Raises Bid To $53 Billion To Buy Allergan, Inc. (NYSE:AGN)

Boston, MA 06/02/2014 (wallstreetpr) – Valeant Pharmaceuticals Intl Inc (NYSE:VRX) increased its offer to acquire Allergan, Inc. (NYSE:AGN) for the second time in the week. Second Raise In A Week The Canada based drug maker said on Friday that it is agreeable to offer $72 and in addition a part of its stock for each […]